MOMTAZEE JAMES C
SEC CIK 1209181 · EDGAR
BoughtSold
Most active insiders at ROIV, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | MANCHESTER KEITH S | Dir | — | $154.47M |
| 2 | Gold Daniel Allen | Dir | — | $147.38M |
| 3 | QVT Financial LP | Dir by Deputization | — | $147.38M |
| 4 | Sukhatme Mayukh | Pres, CIO, Dir | — | $109.13M |
| 5 | Ramaswamy Vivek | 10% | — | $105.88M |
| 6 | Venker Eric | Pres, Immunovant CEO | — | $89.77M |
| 7 | Torti Frank | Pres, Vant COB | — | $82.04M |
| 8 | Gline Matthew | CEO, Dir | — | $46.17M |
| 9 | Pulik Richard | CFO | — | $9.12M |
| 10 | Fitzgerald Meghan | Dir | — | $3.27M |
| 14 | MOMTAZEE JAMES C | Dir | — | — |
Transactions 37
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-09-18 19:01 | 2026-09-16 | ROIV | Roivant Sciences Ltd. | MOMTAZEE JAMES C | Dir | A - Grant | $0.00 | +5,054 | 112.0K | +5% | $0 |
| 2026-09-14 18:25 | 2026-09-10 | ROIV | Roivant Sciences Ltd. | MOMTAZEE JAMES C | Dir | F - Tax | $40.94 | -2,905 | 106.9K | -3% | -$118.9K | |
| 2026-07-21 21:00 | 2026-07-17 | ROIV | Roivant Sciences Ltd. | MOMTAZEE JAMES C | Dir | A - Grant | $0.00 | +405 | 109.8K | +0.4% | $0 | |
| D | 2026-06-24 18:05 | 2026-06-22 | BBIO | BridgeBio Pharma, Inc. | MOMTAZEE JAMES C | Dir | A - Grant | $0.00 | +3,990 | 19.1K | +26% | $0 |
| 2026-04-21 18:32 | 2026-04-17 | ROIV | Roivant Sciences Ltd. | MOMTAZEE JAMES C | Dir | A - Grant | $0.00 | +469 | 109.5K | +0.4% | $0 | |
| 2026-04-21 18:32 | 2026-04-17 | ROIV | Roivant Sciences Ltd. | MOMTAZEE JAMES C | Dir | F - Tax | $29.83 | -94 | 109.4K | -0.1% | -$2,804 | |
| 2026-01-22 | 2026-01-20 | ROIV | Roivant Sciences Ltd. | MOMTAZEE JAMES C | Dir | F - Tax | $22.98 | -122 | 109.0K | -0.1% | -$2,804 | |
| 2026-01-22 | 2026-01-20 | ROIV | Roivant Sciences Ltd. | MOMTAZEE JAMES C | Dir | A - Grant | $0.00 | +609 | 109.2K | +0.6% | $0 | |
| 2025-10-22 | 2025-10-20 | ROIV | Roivant Sciences Ltd. | MOMTAZEE JAMES C | Dir | A - Grant | $0.00 | +789 | 108.7K | +0.7% | $0 | |
| 2025-10-22 | 2025-10-20 | ROIV | Roivant Sciences Ltd. | MOMTAZEE JAMES C | Dir | F - Tax | $17.74 | -158 | 108.5K | -0.1% | -$2,803 | |
| D | 2025-09-12 | 2025-09-10 | ROIV | Roivant Sciences Ltd. | MOMTAZEE JAMES C | Dir | J - Other | $13.77 | -3,282 | 107.9K | -3% | -$45.2K |
| D | 2025-09-12 | 2025-09-10 | ROIV | Roivant Sciences Ltd. | MOMTAZEE JAMES C | Dir | A - Grant | $0.00 | +14.5K | 111.2K | +15% | $0 |
| 2025-07-21 | 2025-07-17 | ROIV | Roivant Sciences Ltd. | MOMTAZEE JAMES C | Dir | A - Grant | $0.00 | +1,201 | 96.9K | +1% | $0 | |
| 2025-07-21 | 2025-07-17 | ROIV | Roivant Sciences Ltd. | MOMTAZEE JAMES C | Dir | F - Tax | $11.65 | -241 | 96.7K | -0.2% | -$2,808 | |
| D | 2025-06-24 | 2025-06-20 | BBIO | BridgeBio Pharma, Inc. | MOMTAZEE JAMES C | Dir | A - Grant | $0.00 | +6,589 | 95.1K | +7% | $0 |
| 2025-04-21 | 2025-04-17 | ROIV | Roivant Sciences Ltd. | MOMTAZEE JAMES C | Dir | A - Grant | $0.00 | +1,379 | 96.0K | +1% | $0 | |
| 2025-04-21 | 2025-04-17 | ROIV | Roivant Sciences Ltd. | MOMTAZEE JAMES C | Dir | F - Tax | $10.15 | -276 | 95.7K | -0.3% | -$2,801 | |
| 2025-01-27 | 2025-01-23 | ROIV | Roivant Sciences Ltd. | MOMTAZEE JAMES C | Dir | A - Grant | $0.00 | +1,248 | 94.9K | +1% | $0 | |
| 2025-01-27 | 2025-01-23 | ROIV | Roivant Sciences Ltd. | MOMTAZEE JAMES C | Dir | F - Tax | $11.21 | -306 | 94.6K | -0.3% | -$3,430 | |
| 2024-10-23 | 2024-10-21 | ROIV | Roivant Sciences Ltd. | MOMTAZEE JAMES C | Dir | A - Grant | $0.00 | +1,231 | 93.7K | +1% | $0 | |
| 2024-09-16 | 2024-09-12 | ROIV | Roivant Sciences Ltd. | MOMTAZEE JAMES C | Dir | J - Other | $12.12 | -3,056 | 92.4K | -3% | -$37.0K | |
| D | 2024-09-12 | 2024-09-10 | ROIV | Roivant Sciences Ltd. | MOMTAZEE JAMES C | Dir | A - Grant | $0.00 | +16.4K | 95.5K | +21% | $0 |
| 2024-07-25 | 2024-07-23 | ROIV | Roivant Sciences Ltd. | MOMTAZEE JAMES C | Dir | A - Grant | $0.00 | +1,555 | 79.1K | +2% | $0 | |
| T | 2024-04-26 | 2024-04-24 | ROIV | Roivant Sciences Ltd. | MOMTAZEE JAMES C | Dir | A - Grant | $0.00 | +1,490 | 77.8K | +2% | $0 |
| T | 2024-04-26 | 2024-04-24 | ROIV | Roivant Sciences Ltd. | MOMTAZEE JAMES C | Dir | F - Tax | $10.90 | -293 | 77.5K | -0.4% | -$3,194 |
| 2024-01-23 | 2024-01-19 | ROIV | Roivant Sciences Ltd. | MOMTAZEE JAMES C | Dir | A - Grant | $0.00 | +1,570 | 76.3K | +2% | $0 | |
| T | 2023-10-18 | 2022-10-16 | ROIV | Roivant Sciences Ltd. | MOMTAZEE JAMES C | Dir | A - Grant | $0.00 | +1,594 | 75.5K | +2% | $0 |
| T | 2023-10-18 | 2023-10-17 | ROIV | Roivant Sciences Ltd. | MOMTAZEE JAMES C | Dir | J - Other | $10.30 | -687 | 74.8K | -0.9% | -$7,076 |
| 2023-09-20 | 2023-09-18 | ROIV | Roivant Sciences Ltd. | MOMTAZEE JAMES C | Dir | J - Other | $11.17 | -6,752 | 73.9K | -8% | -$75.4K | |
| D | 2023-09-14 | 2023-09-12 | ROIV | Roivant Sciences Ltd. | MOMTAZEE JAMES C | Dir | A - Grant | $0.00 | +17.8K | 80.6K | +28% | $0 |
| 2023-07-06 | 2023-07-03 | ROIV | Roivant Sciences Ltd. | MOMTAZEE JAMES C | Dir | A - Grant | $0.00 | +1,664 | 62.8K | +3% | $0 | |
| 2023-04-05 | 2023-04-03 | ROIV | Roivant Sciences Ltd. | MOMTAZEE JAMES C | Dir | A - Grant | $0.00 | +1,351 | 61.1K | +2% | $0 | |
| 2023-01-05 | 2023-01-03 | ROIV | Roivant Sciences Ltd. | MOMTAZEE JAMES C | Dir | A - Grant | $0.00 | +2,447 | 59.8K | +4% | $0 | |
| 2022-11-02 | 2022-10-31 | ROIV | Roivant Sciences Ltd. | MOMTAZEE JAMES C | Dir | A - Grant | $0.00 | +3,404 | 57.3K | +6% | $0 | |
| D | 2022-09-19 | 2022-09-15 | ROIV | Roivant Sciences Ltd. | MOMTAZEE JAMES C | Dir | A - Grant | $0.00 | +50.0K | 53.9K | +1,275% | $0 |
| 2022-07-25 | 2022-07-20 | ROIV | Roivant Sciences Ltd. | MOMTAZEE JAMES C | Dir | A - Grant | $0.00 | +3,923 | 3,923 | New | $0 | |
| 2022-01-03 | 2021-12-29 | BBIO | BridgeBio Pharma, Inc. | MOMTAZEE JAMES C | Dir | P - Purchase | $14.50 | +80.0K | 88.5K | +942% | +$1.16M |
Purchase Sale Sale after option exercise All abbreviations